Why the study?
Does intravenous GLP-1 modulate the blood pressure, heart rate, and splanchnic blood flow responses to intraduodenal glucose in healthy older subjects?
Does intravenous GLP-1 modulate the blood pressure, heart rate, and splanchnic blood flow responses to intraduodenal glucose in healthy older subjects?
Acute administration of GLP-1 attenuates the hypotensive response to enteral glucose and increases mesenteric blood flow in healthy older adults.
Answers are grounded in this paper and cite their sources.
May blunt postprandial hypotension in older adults; extends GLP-1 hemodynamic actions to splanchnic flow.
CONTEXT: Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR). OBJECTIVE: To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects. DESIGN: A double-blind randomized trial was conducted. SETTING: Community-dwelling residents attended a clinical research laboratory. PATIENTS: Ten healthy "older" subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied. INTERVENTIONS: Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = -30-60 min). Between t = 0-60 min, ID glucose was infused at 3 kcal/min. MAIN OUTCOME MEASURES: BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured. RESULTS: During the fasting period (t = -30-0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0-60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05). CONCLUSIONS: In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow.
No takes yet. Share an insight, caveat, or question.
Trahair et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: